Formålet med undersøgelsen var at bestemme den optimale valsartandosis til reduktion af UAE hos hypertensive patienter med type - diabetes.
The purpose of the study was to determine the optimal dose of valsartan for reducing UAE in hypertensive patients with type 2 diabetes.